Indo Borax & Chemicals Pledges 14% Stake in Kronox Lab Sciences
Kronox Lab Sciences Ltd 路 Encumbered Shares - Invocation / Release 路 11 Nov 2026, 5:33 pm
Indo Borax & Chemicals Pledges 14% Stake in Kronox Lab Sciences Indo Borax & Chemicals Limited created a pledge on 51,94,560 equity shares (14% of total share capital and 21.79% of promoter holding) of Kronox Lab Sciences Limited on 3rd Nov'26. The pledge was executed in favor of CTL Trusteeship Limited as security for a term loan facility of ~Rs 225 crore availed from Poonawalla Fincorp Ltd. The borrowed funds are being utilized to finance the acquisition of Kronox Lab Sciences' equity shares. Total promoter holding stands at 64.26% (2,38,44,000 shares).
Original exchange filing (PDF)
More announcements from Kronox Lab Sciences Ltd
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd 路 06 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 05, 2026 for Indo Borax & Chemicals Ltd 路 06 Nov 2026
- IIFL Capital Services Ltd (formerly known as IIFL Securities Ltd) ("Manager to the Open Offer") has submitted to BSE a copy of Offer Opening Public Announcement in accordance with Regulation .... 路 05 Nov 2026
- Results -Financail Resutls for the Quarter and Half Year ended September 30, 2026 路 05 Nov 2026
- Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Outcome of Board Meeting held on Thursday, November 05, 2026 inter to consider and approve unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026 路 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 05 Nov 2026
